DAIGNEAULT ALESSANDRA (General Counsel & Secretary) received a stock award from NRX PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/10/2021ACC: 0000950142-21-001937
Officer· General Counsel & Secretary
Since May 2021
+348.56K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
348.56K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.32K
Price / share
—
Trade value
—
% of position
New position
5/24/2021
0.00→6.32K
Total
Net shares
+6.32K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/24/2021 | A · Award | +6.32K | — | — | New position | 0.00 | 6.32K |
| Total | +6.32K | $0.00 | ||||||
Derivative Transactions3
Employee Stock Option (Right to buy)
Direct
Converts to
Common Stock
143.84K shares
Shares
+143.84K
Strike price
3.08
Held after
143.84K
Exercisable
—
5/24/2021
Employee Stock Option (Right to buy)
Direct
Converts to
Common Stock
49.60K shares
Shares
+49.60K
Strike price
3.08
Held after
49.60K
Exercisable
—
5/24/2021
Employee Stock Option (Right to buy)
Direct
Converts to
Common Stock
148.80K shares
Shares
+148.80K
Strike price
72.30
Held after
148.80K
Exercisable
—
5/24/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to buy) Direct | Common Stock143.84K shares | 5/24/2021 | A · Award | +143.84K | 3.08 | — | 143.84K |
| Employee Stock Option (Right to buy) Direct | Common Stock49.60K shares | 5/24/2021 | A · Award | +49.60K | 3.08 | — | 49.60K |
| Employee Stock Option (Right to buy) Direct | Common Stock148.80K shares | 5/24/2021 | A · Award | +148.80K | 72.30 | — | 148.80K |